Treatment of advanced renal cell cancer with sequential intravenous recombinant interleukin-2 and subcutaneous α-interferon
- 31 December 1994
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (9), 1292-1298
- https://doi.org/10.1016/0959-8049(94)90176-7
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Karnofsky Memorial Lecture. The immunotherapy and gene therapy of cancer.Journal of Clinical Oncology, 1992
- A phase II trial of interleukin‐2 by continuous infusion and interferon by intramuscular injection in patients with renal cell carcinomaCancer, 1991
- HLA‐class‐I and‐class‐II expression on renal tumor xenografts and the relation to sensitivity for α‐IFN, γ‐IFN and TNFInternational Journal of Cancer, 1991
- Vinblastine fails to improve response of renal cancer to interferon alfa-n1: high response rate in patients with pulmonary metastases.Journal of Clinical Oncology, 1991
- Recombinant interleukin-2 and lymphokine-activated killer cells in renal cancer patients: I. phenotypic and functional analysis of the peripheral blood mononuclear cellsCancer Immunology, Immunotherapy, 1990
- New Approaches to the Immunotherapy of Cancer Using Interleukin-2Annals of Internal Medicine, 1988
- Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced CancerNew England Journal of Medicine, 1987
- Interferons in the treatment of human cancer.Journal of Clinical Oncology, 1984
- Reporting results of cancer treatmentCancer, 1981
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958